chr17-6434084-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_014336.5(AIPL1):​c.111C>T​(p.Phe37Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0262 in 1,613,834 control chromosomes in the GnomAD database, including 748 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.019 ( 58 hom., cov: 30)
Exomes 𝑓: 0.027 ( 690 hom. )

Consequence

AIPL1
NM_014336.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:2

Conservation

PhyloP100: 2.40

Publications

5 publications found
Variant links:
Genes affected
AIPL1 (HGNC:359): (aryl hydrocarbon receptor interacting protein like 1) Leber congenital amaurosis (LCA) is the most severe inherited retinopathy with the earliest age of onset and accounts for at least 5% of all inherited retinal diseases. Affected individuals are diagnosed at birth or in the first few months of life with nystagmus, severely impaired vision or blindness and an abnormal or flat electroretinogram. The photoreceptor/pineal-expressed gene, AIPL1, encoding aryl-hydrocarbon interacting protein-like 1, is located within the LCA4 candidate region. The encoded protein contains three tetratricopeptide motifs, consistent with chaperone or nuclear transport activity. Mutations in this gene may cause approximately 20% of recessive LCA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
AIPL1 Gene-Disease associations (from GenCC):
  • AIPL1-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Leber congenital amaurosis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 17-6434084-G-A is Benign according to our data. Variant chr17-6434084-G-A is described in ClinVar as Benign. ClinVar VariationId is 99789.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
Synonymous conserved (PhyloP=2.39 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0191 (2905/152166) while in subpopulation NFE AF = 0.0285 (1940/67996). AF 95% confidence interval is 0.0275. There are 58 homozygotes in GnomAd4. There are 1469 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 58 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIPL1NM_014336.5 linkc.111C>T p.Phe37Phe synonymous_variant Exon 2 of 6 ENST00000381129.8 NP_055151.3 Q9NZN9-1F1T0B6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIPL1ENST00000381129.8 linkc.111C>T p.Phe37Phe synonymous_variant Exon 2 of 6 1 NM_014336.5 ENSP00000370521.3 Q9NZN9-1

Frequencies

GnomAD3 genomes
AF:
0.0191
AC:
2905
AN:
152048
Hom.:
58
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00544
Gnomad AMI
AF:
0.0396
Gnomad AMR
AF:
0.00701
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0518
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0285
Gnomad OTH
AF:
0.0149
GnomAD2 exomes
AF:
0.0206
AC:
5159
AN:
250950
AF XY:
0.0205
show subpopulations
Gnomad AFR exome
AF:
0.00542
Gnomad AMR exome
AF:
0.00440
Gnomad ASJ exome
AF:
0.00348
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0496
Gnomad NFE exome
AF:
0.0322
Gnomad OTH exome
AF:
0.0229
GnomAD4 exome
AF:
0.0269
AC:
39323
AN:
1461668
Hom.:
690
Cov.:
33
AF XY:
0.0261
AC XY:
19009
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.00397
AC:
133
AN:
33480
American (AMR)
AF:
0.00501
AC:
224
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00386
AC:
101
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00106
AC:
91
AN:
86226
European-Finnish (FIN)
AF:
0.0495
AC:
2637
AN:
53316
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5764
European-Non Finnish (NFE)
AF:
0.0315
AC:
35065
AN:
1111956
Other (OTH)
AF:
0.0174
AC:
1049
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
2285
4570
6856
9141
11426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1284
2568
3852
5136
6420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0191
AC:
2905
AN:
152166
Hom.:
58
Cov.:
30
AF XY:
0.0197
AC XY:
1469
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00542
AC:
225
AN:
41508
American (AMR)
AF:
0.00700
AC:
107
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000622
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
0.0518
AC:
550
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0285
AC:
1940
AN:
67996
Other (OTH)
AF:
0.0147
AC:
31
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
132
264
396
528
660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0238
Hom.:
43
Bravo
AF:
0.0162
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0232
EpiControl
AF:
0.0237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2Other:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Retina International
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

-
NEI Ophthalmic Genomics Laboratory, National Institutes of Health
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leber congenital amaurosis 4 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis Pigmentosa, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
6.7
DANN
Benign
0.90
PhyloP100
2.4
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11650007; hg19: chr17-6337404; API